Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goreisan (TJ-17) for nocturia due to nocturnal polyuria with lower-leg edema
jRCT1071250124Recruiting
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oreongsan in nocturia, nocturnal polyuria (NP) and peripheral edema. Primary endpoint: Nighttime voiding frequency. Started Jan 2026; status: recruiting.
02
Drugs
oreongsan
03
Conditions
nocturianocturnal polyuria (NP)peripheral edema
Beyond the preview
Go deeper on jRCT1071250124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071250124.